Document is current

Article History

Received: 26 July 2021

Accepted: 27 February 2022

First Online: 16 March 2022

Declarations

:

: All authors declare that they have no competing interests, no support from any organization for the submitted work, and no financial relationship with any organizations that might have an interest in the submitted work. No pharmaceutical or biotechnology company, foundation, or any other source participated in the design, monitoring, data collection, and analysis. Dr. Juan Carlos Ramírez Sandoval has received honoraria from Takeda Mexico (speakers’ bureau), Roche Mexico (speakers’ bureau), Amgen Mexico (speakers’ bureau), Valdecasas Mexico (research funding), and Mercurio S.A. de C.V (advisory). Dr. Ricardo Correa Rotter is a member of the Review Board of Blood Purification, has received honoraria from AbbVie, AstraZeneca, GlaxoSmithKline, and Boehringer Ingelheim, and has lectured for Amgen, Takeda, AstraZeneca, and Roche. Dr. Diener-Cabieses Pablo, Gutiérrez-Valle Fabián, Ley-Tapia Sofía, Pastrana-Brandes Santiago, Galindo Pablo E., Reynerio Fagundo, Moreno-Yañez M., and Reza-Albarrán Alfredo Adolfo have no conflicts of interest to declare.

: The study was approved by the institutional review board (reference number 3204). Patients’ written informed consent was exempted because of the retrospective nature of study.

: Not applicable.

: All authors give our consent for the submission and publication of the paper in International Urology and Nephrology.